- Home
- NXPLW vs FTEL Comparison
NXPLW vs FTEL Comparison
Compare NXPLW & FTEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NXPLW
- FTEL
- Stock Information
- Founded
- NXPLW N/A
- FTEL 2007
- Country
- NXPLW United States
- FTEL Australia
- Employees
- NXPLW 166
- FTEL N/A
- Industry
- NXPLW Telecommunications Equipment
- FTEL
- Sector
- NXPLW Telecommunications
- FTEL
- Exchange
- NXPLW Nasdaq
- FTEL Nasdaq
- Market Cap
- NXPLW N/A
- FTEL N/A
- IPO Year
- NXPLW N/A
- FTEL 2023
- Fundamental
- Price
- NXPLW $0.16
- FTEL $0.61
- Analyst Decision
- NXPLW
- FTEL
- Analyst Count
- NXPLW 0
- FTEL 0
- Target Price
- NXPLW N/A
- FTEL N/A
- AVG Volume (30 Days)
- NXPLW 6.4K
- FTEL 100.7K
- Earning Date
- NXPLW 03-31-2025
- FTEL 05-06-2025
- Dividend Yield
- NXPLW N/A
- FTEL N/A
- EPS Growth
- NXPLW N/A
- FTEL N/A
- EPS
- NXPLW N/A
- FTEL N/A
- Revenue
- NXPLW $66,482,000.00
- FTEL $4,466,775.00
- Revenue This Year
- NXPLW N/A
- FTEL N/A
- Revenue Next Year
- NXPLW N/A
- FTEL N/A
- P/E Ratio
- NXPLW N/A
- FTEL N/A
- Revenue Growth
- NXPLW 179.89
- FTEL N/A
- 52 Week Low
- NXPLW $0.25
- FTEL $0.51
- 52 Week High
- NXPLW $0.26
- FTEL $49.50
- Technical
- Relative Strength Index (RSI)
- NXPLW N/A
- FTEL 36.03
- Support Level
- NXPLW N/A
- FTEL $0.61
- Resistance Level
- NXPLW N/A
- FTEL $0.70
- Average True Range (ATR)
- NXPLW 0.00
- FTEL 0.06
- MACD
- NXPLW 0.00
- FTEL 0.07
- Stochastic Oscillator
- NXPLW 0.00
- FTEL 33.19
About NXPLW NextPlat Corp
NextPlat Corp is a global e-commerce and healthcare company. Its e-commerce venues form an effective global network serving thousands of consumers, enterprises, and governments. Its healthcare business is focused on improving the lives of patients with complex chronic diseases through patient and provider engagement and their partnerships with payors, pharmaceutical manufacturers, and distributors, offering a broad range of solutions to address the dispensing, delivery, dosing, and reimbursement of clinically intensive, high-cost drugs. The company operate in two segments: e-Commerce Business and Healthcare Business.